ProPhase Labs

• 1: Home
• 2: About Us
• 3: Business Units
  • 3.1: Cold-EEZE
  • 3.2: Quigley Pharma
  • 3.3: Quigley Manufacturing
  • 3.4: Phusion Laboratories
• 4: Investor Relations
  • 4.1: Annual Reports
  • 4.2: Review Our SEC Filings
  • 4.3: SEC Form 3, 4, & 5 Reporting
  • 4.4: Investor Kit Request
  • 4.6: Corporate Policies
• 5: News & Events
  • 5.1: ProPhase Labs News Releases
    • 5.1.1: Quigley Corporation Archived News
  • 5.2: Quigley Pharma News Releases
    • 5.2.1: Quigley Pharma Archived News Releases
• 6: Contact Us
• 8: Legal
  • 8.1: Privacy Policy
  • 8.2: Corporate Policies
• 16: Careers

About Us

Mission

Our mission is to develop and market natural health care pharmaceuticals and nutriceuticals that offer pioneering new options to improve patient treatment results. Our core objective is to address the root cause of illness with the goal of exceeding the efficacy and safety of current treatment options. This approach includes the development of natural compounds and unique methods to deliver those compounds in an effort to innovate medical science and improve patient outcomes.

Consumer Health

Our consumer health products, marketed through ProPhase Labs and certain subsidiaries, include the original COLD-EEZE®. COLD-EEZE® contains the only safe and effective natural formula that has been shown to significantly reduce the duration of the common cold in repeated clinical trials. It offers a significant advancement over the majority of cough/cold products available over-the-counter, which do not reduce the duration of the common cold. A recent retrospective analysis also suggests that COLD-EEZE® is an effective means of prevention. The study indicated that when taken daily, COLD-EEZE® statistically lessens the number of colds an individual suffers per year, reducing the median from 1.5 to zero. The scientific results of clinical testing have propelled COLD-EEZE® to a top selling Cough Cold brand in record time.

Ethical Pharmaceuticals

The mission and philosophy of ProPhase Labs extends to its wholly owned subsidiaries, including a Pharma division, which conducts research in order to develop and commercialize a pipeline of patented botanical and naturally derived potential prescription drugs. The Pharma division combines the rigor of traditional pharmaceutical research with an eye toward revolutionary technologies and treatment approaches to effectively improve the health and wellness of society. The research pipeline for the Pharma division includes several natural compounds currently undergoing rigorous analysis for their application with difficult-to-treat disease states. The goal is to confirm the efficacy of these compounds according to the requirements set forth by the U.S. Food & Drug Administration in order to market them as ethical pharmaceuticals.